Jefferies Starts Cue Biopharma (CUE) at Buy, 'Following Nature's "Cues" W/ Targeted IL-2 Therapy'

Go back to Jefferies Starts Cue Biopharma (CUE) at Buy, 'Following Nature's "Cues" W/ Targeted IL-2 Therapy'
(NASDAQ: CUE) Delayed: 31.08 --0 (-0%)
Previous Close $31.08    52 Week High
Open $31.08    52 Week Low
Day High $31.08    P/E N/A 
Day Low $31.08    EPS
Volume 152